The University of Texas Health at San Antonio has enabled the launch of more than 50 companies from technologies developed by UTHSA faculty and staff.
UPDATED January 11, 2021:
Avox (Acquired, Acriva) - Lightweight, battery-powered, portable blood analyzer, known as an oximeter, to measure oxygen, hemoglobin and other substances in blood and also useful for diagnosing problems, such as, heart defects.
Osteobiologics (Acquired, 2006, Smith-Nephew) - Innovative bioabsorbable bone graft substitutes (BGS) to repair cartilage defects in the knee
Vidacare (Acquired, 2013, Teleflex) - Patented power driver and needle system to access the intraosseous space for a variety of medical, diagnostic and therapeutic purposes. Vidacare's proprietary devices are the recognized technology standard used in a broad range of applications including vascular access, emergency medicine, oncology, and spinal surgery.
Advanced Bio ProSthetic, Ltd. - Palmaz cardiovascular stent
Xenotope Diagnostics, Inc. - Develops novel solutions for global diseases through the implementation of its expertise in infectious disease research and unique discovery platform.
Admittance Technologies - Innovative electrical engineering solutions
Cerebral Eidetics - Revoluntionary core-technology, image-guided, robotic transcranial magnetic stimulation (irTMS). irTMS is a "personalized medicine" individually mapping each patient's brain connectome with functional MRI to create an optimized treatment plan.
Cardio Spectra (Acquired, 2007, Volcano) - Innovative Optical Coherence Tomography (OCT) imaging technology for the diagnosis and treatment of diseases
Numira Biosciences, Inc. - High resolution MicroCT small animal imaging services
StemBioSys, Inc. - Enabling innovative regenerative medicine solutions with the novel High Performance Microenvironment (HPMETM) platform. Stem cell technologies for research and therapeutic pipelines
Cardiovate, Inc. - Innovative devices for repair of cardiovascular conditions
Rapamycin Holdings (DBA, Emtora, Inc.) - Leveraging a platform of Rapamycin-related discoveries applicable to the veterinary and human markets. These discoveries could have dramatic implications in improving an individual's health-span and in fighting age-related medical conditions.
Astrocyte Pharmaceuticals, Inc. - Developing innovative neuroprotection therapies for traumatic brain injury (TBI), concussions, stroke, and neurodegenerative disorders
Echolase, Inc. - Revolutionary acoustic sensor based on the patent pending probe beam deflection technology (PBDT)
Advanced Surgical Retractor Systems, Inc.
Strong North Wind
Lonestar Sciences Inc.
Riverwalk Therapeutics, Inc.